Imaging Biometrics, a wholly owned subsidiary of IQ-AI, is highlighting results from a recent study published in the American Journal of Neuroradiology.
The study, led by Michael Iv, MD, from the Stanford University Medical Center, found that dynamic susceptibility contrast (DSC) MR perfusion improved interreader agreement and confidence in neuroradiologist interpretation. The company touted that its DSC-fractional tumor burden (FTB) resulted in the highest agreement in BT-RADS scores among all raters as well as the highest confidence scores for interpretation.
The company also noted the high level of agreement with the DSC-FTB despite the range of practice experience.
Additionally, perfusion MRI resulted in interpretation changes that could alter therapeutic management in up to 20% of patients, the company highlighted. Imaging Biometrics' FTB maps are generated from the company's Delta T1 and Neuro standardized relative cerebral blood volume maps. The quantitative maps also make way for direct volumetric comparison across time to monitor response to treatment, the company said.
![Coronal and axial slice of the average cortical F-18 MK-6240 SUVR [standard uptake value ratio] image for each study population. SUVR images were corrected for partial volume effects and masked with the gray matter mask used for volume of interest delineation. Overall tau accumulation is comparable between the late-life depression (LLD, middle column) and non-depressed cognitively unimpaired comparison (HC, left column) groups, while abnormal tau accumulation, which is most pronounced in the mesial temporal lobe, can be seen in the mild cognitive impairment due to Alzheimer's disease group (right column). Image and caption courtesy of the American Journal of Geriatric Psychiatry.](https://img.auntminnie.com/files/base/smg/all/image/2024/07/Tau_depressed.66a16540ee0a1.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)